HCWC director granted 237,500 vested shares

Myers Behnam reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Myers Behnam reported acquisition or exercise transactions in this Form 4 filing.

HEALTHY CHOICE WELLNESS CORP. director Myers Behnam received a restricted stock award of 237,500 shares of Class A Common Stock that vested effective June 2, 2026, pursuant to award agreements. The shares were granted at no cash cost, increasing Behnam’s direct holdings to 300,000 shares.

Insider Trade Summary

Grant/Award: 237,500 shares

Grant/Award 1 txn

Insider Myers Behnam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	237,500	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 300,000 shares (Direct)

Footnotes (1)

F1. Restricted stock award of 237,500 shares vested pursuant to applicable award agreements effective as of June 2, 2026.

Key Figures

Restricted shares vested: 237,500 shares Shares held after transaction: 300,000 shares Grant price per share: $0.0000 per share +1 more

4 metrics

Restricted shares vested 237,500 shares Restricted stock award effective June 2, 2026

Shares held after transaction 300,000 shares Total direct Class A Common Stock after award vesting

Grant price per share $0.0000 per share Compensation grant, not open-market purchase

Transaction date June 2, 2026 Effective vesting date of restricted stock award

Key Terms

Restricted stock award, Class A Common Stock, Grant, award, or other acquisition, total_shares_following_transaction

4 terms

Restricted stock award financial

"Restricted stock award of 237,500 shares vested pursuant to applicable award agreements"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Class A Common Stock financial

"security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

total_shares_following_transaction financial

""total_shares_following_transaction": "300000.0000""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HCWC director Myers Behnam report on this Form 4?

Myers Behnam reported receiving a restricted stock award of 237,500 Class A Common Stock shares. The award vested effective June 2, 2026, under applicable award agreements, reflecting equity-based compensation rather than an open-market stock purchase.

How many HCWC shares does Myers Behnam hold after the reported Form 4 transaction?

After the transaction, Myers Behnam directly holds 300,000 shares of HEALTHY CHOICE WELLNESS CORP. Class A Common Stock. This total includes the 237,500 restricted shares that vested on June 2, 2026, as part of the reported equity award.

Was cash paid for the HCWC shares in Myers Behnam’s Form 4 transaction?

No cash was paid for these HCWC shares. The Form 4 reports a transaction price per share of $0.0000, indicating the 237,500 Class A shares were granted as a restricted stock award under compensation arrangements.

What does the footnote in Myers Behnam’s HCWC Form 4 filing explain?

The footnote explains that the 237,500 shares represent a restricted stock award that vested pursuant to applicable award agreements, effective as of June 2, 2026. This clarifies the transaction is a vesting event, not an open-market trade.

Is Myers Behnam’s HCWC Form 4 transaction a purchase or an equity award vesting?

The transaction is an equity award vesting, not a purchase. The filing classifies it as a grant, award, or other acquisition, with 237,500 restricted shares of Class A Common Stock vesting effective June 2, 2026, at zero cash cost.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/04/2026 - 07:25 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Myers Behnam

(Last)

(First)

(Middle)

3800 NORTH 28TH WAY, UNIT 1

(Street)

HOLLYWOOD

FLORIDA

33020

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/02/2026		A⁽¹⁾		237,500	A	$0.00	300,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock award of 237,500 shares vested pursuant to applicable award agreements effective as of June 2, 2026.

	/s/ Martin Schrier, as Attorney-in-Fact For Behnam Myers	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR